Skip to main content
Acta Crystallographica Section E: Crystallographic Communications logoLink to Acta Crystallographica Section E: Crystallographic Communications
. 2018 Nov 30;74(Pt 12):1919–1922. doi: 10.1107/S2056989018016754

Crystal structures of 3-meth­oxy-4-{[5-(4-meth­oxy­phen­yl)-1,3,4-oxa­diazol-2-yl]meth­oxy}benzo­nitrile and N-(4-{[5-(4-chloro­phen­yl)-1,3,4-oxa­diazol-2-yl]meth­oxy}phen­yl)acetamide

K Lakshmithendral a, K Archana a, K Saravanan a, S Kabilan a,*, S Selvanayagam b,
PMCID: PMC6281121  PMID: 30574401

The title heterocyclic 1,3,4-oxa­diazole derivatives differ from each other in the groups attached to the carbon atoms: a meth­oxy­phenyl ring and a benzo­nitrile group in (I) and a chloro­phenyl ring and an acetamide group in (II).

Keywords: crystal structure, oxa­diazole derivatives, superposition, intra­molecular C—H⋯O inter­actions, inter­molecular C—H⋯N and N—H⋯N hydrogen bonds

Abstract

The title compounds, C18H15N3O4 and C17H14ClN3O3, are heterocyclic 1,3,4-oxa­diazole derivatives which differ from each other in the groups attached to the carbon atoms: a meth­oxy­phenyl ring and a benzo­nitrile group in (I) and a chloro­phenyl ring and an acetamide group in (II). Short intra­molecular C—H⋯O hydrogen bonds occur in both mol­ecules. The crystal structure of (I) features C—H⋯N hydrogen bonds, while in the crystal structure of (II), N—H⋯N, C—H⋯N and C—H⋯O hydrogen bonds are observed.

Chemical context  

Oxa­diazole is a versatile heterocyclic nucleus, which has attracted a wide attention of the medicinal chemists for the development of new drugs. Compounds containing a heterocyclic ring system are of great importance both medicinally and industrially (Pace & Pierro, 2009). This stable and neutral hetero aromatic nucleus is associated with potent pharmacological activity that can be attributed to the presence of the toxophoric —N=C—O— linkage (Rigo & Couturier, 1985). Furthermore, 1,3,4-oxa­diazole heterocycles are very good bioisosteres of amides and esters, which can contribute substanti­ally in increasing pharmacological activity by participating in hydrogen-bonding inter­actions with the receptors (Guimaraes et al., 2005). In view of the above importance of the title compounds, we have undertaken single-crystal X-ray diffraction studies for the both compounds and the results are presented here.graphic file with name e-74-01919-scheme1.jpg

Structural commentary  

The mol­ecular structures of (I) and (II) are illustrated in Figs. 1 and 2, respectively. In (I), the 4-meth­oxy­phenyl and oxa­diazole (r.m.s. deviation 0.007  Å) rings are almost coplanar with a dihedral angle of 1.4 (1)°. The meth­oxy atoms O4 and C16 are also coplanar with the rings, deviating by 0.080 (1) and 0.020 (1) Å from the mean plane of the phenyl ring, respectively. In (II), the chloro­phenyl ring is almost coplanar with the oxa­diazole ring, the angle between their mean planes being 4.0 (1)°. The whole mol­ecule is almost planar: the r.m.s. deviation is 0.098 Å and the largest deviation from the mean plane of 0.230 (2) Å is observed for atom C17. Such planarity is not observed in (I) since the meth­oxy­phenyl ring and the benzo­nitrile moiety are oriented at a dihedral angle of 66.8 (1)°. This difference can be seen in Fig. 3, which shows a superposition of the two mol­ecular structures through the oxa­diazole ring (C7/N1/N2/C8/O1) obtained using Qmol (Gans & Shalloway, 2001).

Figure 1.

Figure 1

A view of the mol­ecular structure of compound (I), showing the atom labelling. Displacement ellipsoids are drawn at the 30% probability level. The dashed line represent the intra­molecular C—H⋯O inter­action (Table 1).

Figure 2.

Figure 2

A view of the mol­ecular structure of compound (II), showing the atom labelling. Displacement ellipsoids are drawn at the 30% probability level. The dashed line represents the intra­molecular C—H⋯O inter­action (Table 2).

Figure 3.

Figure 3

Superposition of oxa­diazole ring system of compound (I) (blue) and compound (II)(red).

The mol­ecular structures of both (1) and (II) are influenced by intra­molecular C—H⋯O inter­actions (Tables 1 and 2), which form S(5) ring motifs (Figs. 1 and 2).

Table 1. Hydrogen-bond geometry (Å, °) for (I) .

D—H⋯A D—H H⋯A DA D—H⋯A
C1—H1⋯O1 0.93 2.50 2.835 (6) 101
C9—H9A⋯N1i 0.97 2.57 3.540 (6) 178
C18—H18A⋯N2ii 0.96 2.60 3.470 (6) 151
C16—H16B⋯O3iii 0.96 2.59 3.094 (7) 113

Symmetry codes: (i) Inline graphic; (ii) Inline graphic; (iii) Inline graphic.

Table 2. Hydrogen-bond geometry (Å, °) for (II) .

D—H⋯A D—H H⋯A DA D—H⋯A
C1—H1⋯O1 0.93 2.54 2.853 (3) 100
N3—H3⋯N2i 0.86 2.55 3.377 (3) 161
C1—H1⋯O3i 0.93 2.46 3.359 (3) 163
C14—H14⋯N2i 0.93 2.59 3.443 (3) 152
C17—H17C⋯O3ii 0.96 2.56 3.357 (4) 140

Symmetry codes: (i) Inline graphic; (ii) Inline graphic.

Supra­molecular features  

In the crystal of compound (I), mol­ecules are associated via C—H⋯O inter­actions into inversion dimers (C16—H16B⋯O3iii, Table 1), generating an Inline graphic(30) motif (Fig. 4). Further C—H⋯N hydrogen bonds (C9—H9A⋯N1i, Table 1) link the mol­ecules, forming C(5) chains propagating along [010] (Fig. 5). There is also a weak C—H⋯N inter­action (C18—H18A⋯N2ii, Table 1) that links the mol­ecules, forming C(9) chains propagating in an anti-parallel manner along [110]. These C—H⋯N hydrogen bonds along with the C—H⋯O dimers form a closed cavity shape arrangement consisting of 26 atoms in the unit cell (Fig. 6). In addition, offset π–π inter­actions are observed between the centroids of inversion-related oxa­diazole and 4-meth­oxy­phenyl rings with a centroid–centroid distance of 3.700 (3) Å and a slippage of 1.037 Å.

Figure 4.

Figure 4

The inversion dimer formed in compound (I) via C—H⋯O inter­actions (dashed lines). For clarity H atoms not involved in these hydrogen bonds have been omitted.

Figure 5.

Figure 5

The crystal packing of compound (I) viewed down the b axis. The C—H⋯N hydrogen bonds (see Table 1) are shown as dashed lines. For clarity H atoms not involved in these hydrogen bonds have been omitted.

Figure 6.

Figure 6

The crystal packing of the title compound (I) viewed along the a axis. The C—H⋯N hydrogen bonds and C—H⋯O inter­actions (see Table 1) are shown as dashed lines. For clarity H atoms not involved in these hydrogen bonds have been omitted.

In the crystal of compound (II), mol­ecules are connected by N—H⋯N hydrogen bonds forming C(10) chains, C—H⋯N hydrogen bonds forming C(8) chains and C—H⋯O inter­actions forming C(15) chains (Fig. 7). All these chains propagate along [010] in a helical manner. In addition, C—H⋯O inter­actions involving atoms H17C and O3 are also observed (Table 2). No π–π inter­actions are observed in compound (II) because of the coplanarity between the oxa­diazole and chloro­phenyl rings.

Figure 7.

Figure 7

The crystal packing of (II) viewed along the c axis. The N—H⋯N, C—H⋯N and C—H⋯O inter­actions (see Table 2) are shown as dashed lines. For clarity H atoms not involved in these hydrogen bonds have been omitted.

Synthesis and crystallization  

Compound (I) was synthesized from a solution of 4-hy­droxy-3-meth­oxy­benzo­nitrile (1mmol), K2CO3 (3 mmol) in DMF (4 mL), 2-(chloro­meth­yl)-5-(4-meth­oxy­phen­yl)-1,3,4-oxa­diazole and KI (0.5 mmol). The reaction mixture was stirred at room temperature for about 2 h until the starting material had been consumed (TLC monitoring), and then washed with cold water. The solid product was collected by filtration and dried under vacuum. The pure compound was further recrystallized from ethyl acetate/petroleum ether solution (v:v = 1:1).

Compound (II) was synthesized from a solution of N-(4-hy­droxy­phen­yl)acetamide (1mmol), K2CO3 (3 mmol) in ACN (5mL), 2-(chloro­meth­yl)-5-(4-chloro­phen­yl)-1,3,4-oxa­diazole and KI (0.5 mmol). The reaction mixture was stirred under reflux condition for about 16 h, until completion of the reaction (TLC monitoring), then it was diluted with ethyl acetate (30 mL) and washed with saturated NaHCO3 and cold water. The organic layer was separated, dried over anhydrous Na2SO4 and concentrated under vacuum. The pure compound was further recrystallized from an ethyl acetate/petroleum ether solution (v:v = 1:1), giving colourless block-like crystals suitable for X-ray diffraction analysis.

Refinement  

Crystal data, data collection and structure refinement details are summarized in Table 3. In both crystal structures, H atoms were placed in idealized positions and allowed to ride on their parent atoms: C—H = 0.93–0.97 Å with U iso(H) = 1.5U eq(C-methyl) and 1.2U eq(C) for other H atoms.

Table 3. Experimental details.

  (I) (II)
Crystal data
Chemical formula C18H15N3O4 C17H14ClN3O3
M r 337.33 343.76
Crystal system, space group Triclinic, P Inline graphic Monoclinic, C2/c
Temperature (K) 298 298
a, b, c (Å) 6.0847 (14), 8.5048 (19), 17.286 (4) 42.24 (1), 10.233 (3), 7.496 (2)
α, β, γ (°) 102.668 (7), 90.646 (6), 109.813 (8) 90, 91.016 (11), 90
V3) 817.5 (3) 3239.6 (15)
Z 2 8
Radiation type Mo Kα Mo Kα
μ (mm−1) 0.10 0.26
Crystal size (mm) 0.24 × 0.21 × 0.19 0.22 × 0.20 × 0.18
 
Data collection
Diffractometer Bruker SMART APEX CCD area-detector Bruker SMART APEX CCD area-detector
No. of measured, independent and observed [I > 2σ(I)] reflections 4701, 3593, 1137 8758, 3650, 2733
R int 0.087 0.117
(sin θ/λ)max−1) 0.650 0.649
 
Refinement
R[F 2 > 2σ(F 2)], wR(F 2), S 0.086, 0.282, 0.95 0.063, 0.182, 1.05
No. of reflections 3593 3650
No. of parameters 228 218
H-atom treatment H-atom parameters constrained H-atom parameters constrained
Δρmax, Δρmin (e Å−3) 0.49, −0.33 0.25, −0.36

Computer programs: SMART and SAINT (Bruker, 2002), SHELXS97 (Sheldrick, 2008), SHELXL2018 (Sheldrick, 2015), ORTEP-3 for Windows (Farrugia, 2012) and PLATON (Spek, 2009).

Supplementary Material

Crystal structure: contains datablock(s) I, II, global. DOI: 10.1107/S2056989018016754/zq2243sup1.cif

e-74-01919-sup1.cif (1.1MB, cif)

Structure factors: contains datablock(s) I. DOI: 10.1107/S2056989018016754/zq2243Isup2.hkl

e-74-01919-Isup2.hkl (286.6KB, hkl)

Structure factors: contains datablock(s) II. DOI: 10.1107/S2056989018016754/zq2243IIsup4.hkl

e-74-01919-IIsup4.hkl (291.6KB, hkl)

Supporting information file. DOI: 10.1107/S2056989018016754/zq2243Isup4.cml

Supporting information file. DOI: 10.1107/S2056989018016754/zq2243IIsup5.cml

CCDC references: 1881075, 1881074

Additional supporting information: crystallographic information; 3D view; checkCIF report

supplementary crystallographic information

3-Methoxy-4-{[5-(4-methoxyphenyl)-1,3,4-oxadiazol-2-yl]methoxy}benzonitrile (I). Crystal data

C18H15N3O4 Z = 2
Mr = 337.33 F(000) = 352
Triclinic, P1 Dx = 1.370 Mg m3
a = 6.0847 (14) Å Mo Kα radiation, λ = 0.71073 Å
b = 8.5048 (19) Å Cell parameters from 3118 reflections
c = 17.286 (4) Å θ = 3.2–27.4°
α = 102.668 (7)° µ = 0.10 mm1
β = 90.646 (6)° T = 298 K
γ = 109.813 (8)° Block, colourless
V = 817.5 (3) Å3 0.24 × 0.21 × 0.19 mm

3-Methoxy-4-{[5-(4-methoxyphenyl)-1,3,4-oxadiazol-2-yl]methoxy}benzonitrile (I). Data collection

Bruker SMART APEX CCD area-detector diffractometer Rint = 0.087
Radiation source: fine-focus sealed tube θmax = 27.5°, θmin = 3.1°
ω and φ scans h = −7→7
4701 measured reflections k = −9→10
3593 independent reflections l = −22→14
1137 reflections with I > 2σ(I)

3-Methoxy-4-{[5-(4-methoxyphenyl)-1,3,4-oxadiazol-2-yl]methoxy}benzonitrile (I). Refinement

Refinement on F2 0 restraints
Least-squares matrix: full Hydrogen site location: inferred from neighbouring sites
R[F2 > 2σ(F2)] = 0.086 H-atom parameters constrained
wR(F2) = 0.282 w = 1/[σ2(Fo2) + (0.0956P)2] where P = (Fo2 + 2Fc2)/3
S = 0.95 (Δ/σ)max < 0.001
3593 reflections Δρmax = 0.49 e Å3
228 parameters Δρmin = −0.32 e Å3

3-Methoxy-4-{[5-(4-methoxyphenyl)-1,3,4-oxadiazol-2-yl]methoxy}benzonitrile (I). Special details

Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes.

3-Methoxy-4-{[5-(4-methoxyphenyl)-1,3,4-oxadiazol-2-yl]methoxy}benzonitrile (I). Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2)

x y z Uiso*/Ueq
O1 0.1843 (5) 0.2454 (3) 0.36727 (18) 0.0573 (8)
O2 −0.1120 (5) 0.0785 (3) 0.21803 (19) 0.0672 (10)
O3 −0.2533 (6) −0.2488 (4) 0.16208 (19) 0.0661 (10)
O4 0.6234 (7) 0.1389 (5) 0.6784 (2) 0.0999 (13)
N1 0.5537 (7) 0.3888 (5) 0.3540 (2) 0.0666 (11)
N2 0.4067 (7) 0.3864 (5) 0.2876 (2) 0.0679 (12)
N3 −1.0776 (8) −0.3032 (5) −0.0393 (3) 0.0818 (14)
C1 0.3016 (9) 0.1713 (6) 0.5111 (3) 0.0746 (15)
H1 0.145930 0.131974 0.490115 0.089*
C2 0.3548 (10) 0.1334 (7) 0.5810 (3) 0.0810 (17)
H2 0.235535 0.069914 0.606852 0.097*
C3 0.5834 (10) 0.1892 (7) 0.6124 (3) 0.0737 (15)
C4 0.7621 (9) 0.2890 (7) 0.5738 (3) 0.0744 (15)
H4 0.917781 0.329479 0.594902 0.089*
C5 0.7024 (9) 0.3258 (6) 0.5045 (3) 0.0734 (14)
H5 0.820509 0.392725 0.479518 0.088*
C6 0.4759 (7) 0.2674 (5) 0.4710 (3) 0.0534 (11)
C7 0.4163 (7) 0.3047 (5) 0.3975 (3) 0.0563 (12)
C8 0.1976 (8) 0.3015 (5) 0.2998 (3) 0.0510 (11)
C9 −0.0194 (8) 0.2584 (5) 0.2476 (3) 0.0617 (13)
H9A −0.132615 0.297492 0.277473 0.074*
H9B 0.015621 0.314695 0.203787 0.074*
C10 −0.3104 (7) 0.0114 (5) 0.1662 (3) 0.0524 (11)
C11 −0.4371 (8) 0.1049 (5) 0.1460 (3) 0.0559 (12)
H11 −0.387569 0.222949 0.167178 0.067*
C12 −0.6385 (8) 0.0239 (6) 0.0940 (3) 0.0572 (12)
H12 −0.723785 0.087491 0.080049 0.069*
C13 −0.7123 (8) −0.1506 (6) 0.0632 (2) 0.0531 (11)
C14 −0.5881 (7) −0.2481 (5) 0.0840 (2) 0.0545 (12)
H14 −0.640032 −0.366455 0.063238 0.065*
C15 −0.3888 (8) −0.1680 (5) 0.1354 (3) 0.0545 (12)
C16 0.8476 (11) 0.1995 (8) 0.7151 (4) 0.110 (2)
H16A 0.939257 0.139919 0.684979 0.165*
H16B 0.842598 0.180561 0.767860 0.165*
H16C 0.917417 0.320492 0.718006 0.165*
C17 −0.9170 (9) −0.2349 (6) 0.0064 (3) 0.0621 (13)
C18 −0.3336 (9) −0.4316 (5) 0.1354 (3) 0.0741 (15)
H18A −0.454760 −0.482003 0.166887 0.111*
H18B −0.205201 −0.471141 0.140725 0.111*
H18C −0.394768 −0.464801 0.080479 0.111*

3-Methoxy-4-{[5-(4-methoxyphenyl)-1,3,4-oxadiazol-2-yl]methoxy}benzonitrile (I). Atomic displacement parameters (Å2)

U11 U22 U33 U12 U13 U23
O1 0.0402 (18) 0.0536 (18) 0.059 (2) −0.0017 (14) −0.0116 (15) 0.0045 (15)
O2 0.062 (2) 0.0410 (16) 0.081 (2) 0.0082 (15) −0.0299 (18) −0.0021 (16)
O3 0.065 (2) 0.0469 (18) 0.075 (2) 0.0105 (15) −0.0204 (18) 0.0094 (16)
O4 0.087 (3) 0.126 (3) 0.086 (3) 0.039 (3) −0.016 (2) 0.023 (3)
N1 0.044 (2) 0.072 (3) 0.061 (3) −0.002 (2) 0.002 (2) 0.003 (2)
N2 0.059 (3) 0.069 (3) 0.055 (3) 0.000 (2) 0.004 (2) 0.010 (2)
N3 0.078 (3) 0.074 (3) 0.078 (3) 0.013 (3) −0.027 (3) 0.010 (2)
C1 0.063 (3) 0.078 (3) 0.068 (3) 0.014 (3) −0.021 (3) 0.009 (3)
C2 0.066 (4) 0.098 (4) 0.073 (4) 0.015 (3) −0.003 (3) 0.029 (3)
C3 0.074 (4) 0.083 (4) 0.065 (3) 0.037 (3) −0.007 (3) 0.005 (3)
C4 0.049 (3) 0.089 (4) 0.070 (4) 0.025 (3) −0.021 (3) −0.010 (3)
C5 0.047 (3) 0.078 (3) 0.073 (4) 0.009 (3) −0.011 (3) −0.004 (3)
C6 0.042 (3) 0.049 (2) 0.054 (3) 0.007 (2) −0.005 (2) −0.005 (2)
C7 0.035 (2) 0.047 (2) 0.064 (3) 0.002 (2) −0.006 (2) −0.013 (2)
C8 0.054 (3) 0.041 (2) 0.048 (3) 0.012 (2) 0.002 (2) −0.002 (2)
C9 0.063 (3) 0.041 (2) 0.069 (3) 0.013 (2) −0.020 (3) −0.004 (2)
C10 0.048 (3) 0.039 (2) 0.059 (3) 0.009 (2) −0.013 (2) 0.002 (2)
C11 0.062 (3) 0.043 (2) 0.057 (3) 0.014 (2) −0.008 (2) 0.008 (2)
C12 0.051 (3) 0.058 (3) 0.062 (3) 0.018 (2) −0.005 (2) 0.014 (2)
C13 0.049 (3) 0.058 (3) 0.041 (2) 0.007 (2) −0.002 (2) 0.007 (2)
C14 0.055 (3) 0.048 (2) 0.050 (3) 0.009 (2) −0.011 (2) 0.004 (2)
C15 0.051 (3) 0.045 (2) 0.060 (3) 0.013 (2) −0.013 (2) 0.006 (2)
C16 0.093 (5) 0.145 (6) 0.077 (4) 0.033 (4) −0.019 (4) 0.015 (4)
C17 0.063 (3) 0.053 (3) 0.061 (3) 0.013 (2) −0.011 (3) 0.008 (2)
C18 0.087 (4) 0.049 (3) 0.087 (4) 0.020 (3) 0.006 (3) 0.022 (3)

3-Methoxy-4-{[5-(4-methoxyphenyl)-1,3,4-oxadiazol-2-yl]methoxy}benzonitrile (I). Geometric parameters (Å, º)

O1—C8 1.347 (5) C5—H5 0.9300
O1—C7 1.381 (5) C6—C7 1.446 (6)
O2—C10 1.368 (5) C8—C9 1.480 (6)
O2—C9 1.409 (5) C9—H9A 0.9700
O3—C15 1.371 (5) C9—H9B 0.9700
O3—C18 1.426 (5) C10—C11 1.371 (5)
O4—C3 1.350 (6) C10—C15 1.409 (5)
O4—C16 1.375 (6) C11—C12 1.383 (6)
N1—C7 1.274 (5) C11—H11 0.9300
N1—N2 1.439 (5) C12—C13 1.373 (6)
N2—C8 1.278 (5) C12—H12 0.9300
N3—C17 1.146 (5) C13—C14 1.392 (5)
C1—C2 1.380 (6) C13—C17 1.445 (6)
C1—C6 1.396 (6) C14—C15 1.369 (5)
C1—H1 0.9300 C14—H14 0.9300
C2—C3 1.370 (7) C16—H16A 0.9600
C2—H2 0.9300 C16—H16B 0.9600
C3—C4 1.409 (7) C16—H16C 0.9600
C4—C5 1.377 (6) C18—H18A 0.9600
C4—H4 0.9300 C18—H18B 0.9600
C5—C6 1.369 (6) C18—H18C 0.9600
C8—O1—C7 102.6 (3) C8—C9—H9B 110.0
C10—O2—C9 117.8 (3) H9A—C9—H9B 108.4
C15—O3—C18 116.4 (3) C11—C10—O2 124.7 (4)
C3—O4—C16 119.1 (5) C11—C10—C15 119.8 (4)
C7—N1—N2 106.0 (4) O2—C10—C15 115.4 (3)
C8—N2—N1 105.4 (4) C10—C11—C12 120.2 (4)
C2—C1—C6 121.6 (5) C10—C11—H11 119.9
C2—C1—H1 119.2 C12—C11—H11 119.9
C6—C1—H1 119.2 C13—C12—C11 119.8 (4)
C1—C2—C3 120.0 (5) C13—C12—H12 120.1
C1—C2—H2 120.0 C11—C12—H12 120.1
C3—C2—H2 120.0 C12—C13—C14 120.9 (4)
O4—C3—C2 116.6 (5) C12—C13—C17 120.1 (4)
O4—C3—C4 123.8 (5) C14—C13—C17 119.0 (4)
C2—C3—C4 119.5 (5) C15—C14—C13 119.3 (4)
C5—C4—C3 118.9 (5) C15—C14—H14 120.4
C5—C4—H4 120.5 C13—C14—H14 120.4
C3—C4—H4 120.5 O3—C15—C14 125.3 (4)
C6—C5—C4 122.5 (5) O3—C15—C10 114.7 (4)
C6—C5—H5 118.8 C14—C15—C10 120.0 (4)
C4—C5—H5 118.8 O4—C16—H16A 109.5
C5—C6—C1 117.5 (5) O4—C16—H16B 109.5
C5—C6—C7 121.9 (5) H16A—C16—H16B 109.5
C1—C6—C7 120.7 (4) O4—C16—H16C 109.5
N1—C7—O1 112.4 (4) H16A—C16—H16C 109.5
N1—C7—C6 128.2 (4) H16B—C16—H16C 109.5
O1—C7—C6 119.4 (4) N3—C17—C13 179.0 (6)
N2—C8—O1 113.6 (4) O3—C18—H18A 109.5
N2—C8—C9 127.0 (4) O3—C18—H18B 109.5
O1—C8—C9 119.4 (4) H18A—C18—H18B 109.5
O2—C9—C8 108.3 (3) O3—C18—H18C 109.5
O2—C9—H9A 110.0 H18A—C18—H18C 109.5
C8—C9—H9A 110.0 H18B—C18—H18C 109.5
O2—C9—H9B 110.0
C7—N1—N2—C8 0.3 (5) C7—O1—C8—N2 −0.5 (5)
C6—C1—C2—C3 −0.5 (8) C7—O1—C8—C9 178.1 (3)
C16—O4—C3—C2 −176.1 (5) C10—O2—C9—C8 −178.1 (4)
C16—O4—C3—C4 5.9 (8) N2—C8—C9—O2 114.2 (5)
C1—C2—C3—O4 −176.3 (5) O1—C8—C9—O2 −64.2 (5)
C1—C2—C3—C4 1.7 (8) C9—O2—C10—C11 −5.7 (7)
O4—C3—C4—C5 176.8 (5) C9—O2—C10—C15 176.9 (4)
C2—C3—C4—C5 −1.1 (8) O2—C10—C11—C12 −178.7 (4)
C3—C4—C5—C6 −0.7 (8) C15—C10—C11—C12 −1.4 (7)
C4—C5—C6—C1 1.8 (7) C10—C11—C12—C13 0.4 (7)
C4—C5—C6—C7 −179.0 (4) C11—C12—C13—C14 0.6 (7)
C2—C1—C6—C5 −1.2 (7) C11—C12—C13—C17 −177.4 (4)
C2—C1—C6—C7 179.6 (4) C12—C13—C14—C15 −0.6 (7)
N2—N1—C7—O1 −0.7 (5) C17—C13—C14—C15 177.5 (4)
N2—N1—C7—C6 179.2 (4) C18—O3—C15—C14 −2.0 (7)
C8—O1—C7—N1 0.8 (5) C18—O3—C15—C10 176.9 (4)
C8—O1—C7—C6 −179.2 (4) C13—C14—C15—O3 178.5 (4)
C5—C6—C7—N1 1.4 (7) C13—C14—C15—C10 −0.4 (7)
C1—C6—C7—N1 −179.5 (4) C11—C10—C15—O3 −177.6 (4)
C5—C6—C7—O1 −178.7 (4) O2—C10—C15—O3 −0.1 (6)
C1—C6—C7—O1 0.5 (6) C11—C10—C15—C14 1.4 (7)
N1—N2—C8—O1 0.1 (5) O2—C10—C15—C14 178.9 (4)
N1—N2—C8—C9 −178.3 (4)

3-Methoxy-4-{[5-(4-methoxyphenyl)-1,3,4-oxadiazol-2-yl]methoxy}benzonitrile (I). Hydrogen-bond geometry (Å, º)

D—H···A D—H H···A D···A D—H···A
C1—H1···O1 0.93 2.50 2.835 (6) 101
C9—H9A···N1i 0.97 2.57 3.540 (6) 178
C18—H18A···N2ii 0.96 2.60 3.470 (6) 151
C16—H16B···O3iii 0.96 2.59 3.094 (7) 113

Symmetry codes: (i) x−1, y, z; (ii) x−1, y−1, z; (iii) −x+1, −y, −z+1.

N-(4-{[5-(4-Chlorophenyl)-1,3,4-oxadiazol-2-yl]methoxy}phenyl)acetamide (II) . Crystal data

C17H14ClN3O3 F(000) = 1424
Mr = 343.76 Dx = 1.410 Mg m3
Monoclinic, C2/c Mo Kα radiation, λ = 0.71073 Å
a = 42.24 (1) Å Cell parameters from 5528 reflections
b = 10.233 (3) Å θ = 3.3–27.2°
c = 7.496 (2) Å µ = 0.26 mm1
β = 91.016 (11)° T = 298 K
V = 3239.6 (15) Å3 Block, colourless
Z = 8 0.22 × 0.20 × 0.18 mm

N-(4-{[5-(4-Chlorophenyl)-1,3,4-oxadiazol-2-yl]methoxy}phenyl)acetamide (II) . Data collection

Bruker SMART APEX CCD area-detector diffractometer Rint = 0.117
Radiation source: fine-focus sealed tube θmax = 27.5°, θmin = 3.1°
ω and φ scans h = −52→54
8758 measured reflections k = −13→12
3650 independent reflections l = −6→9
2733 reflections with I > 2σ(I)

N-(4-{[5-(4-Chlorophenyl)-1,3,4-oxadiazol-2-yl]methoxy}phenyl)acetamide (II) . Refinement

Refinement on F2 0 restraints
Least-squares matrix: full Hydrogen site location: inferred from neighbouring sites
R[F2 > 2σ(F2)] = 0.063 H-atom parameters constrained
wR(F2) = 0.182 w = 1/[σ2(Fo2) + (0.0635P)2 + 1.9656P] where P = (Fo2 + 2Fc2)/3
S = 1.05 (Δ/σ)max = 0.002
3650 reflections Δρmax = 0.25 e Å3
218 parameters Δρmin = −0.36 e Å3

N-(4-{[5-(4-Chlorophenyl)-1,3,4-oxadiazol-2-yl]methoxy}phenyl)acetamide (II) . Special details

Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes.

N-(4-{[5-(4-Chlorophenyl)-1,3,4-oxadiazol-2-yl]methoxy}phenyl)acetamide (II) . Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2)

x y z Uiso*/Ueq
Cl1 1.01226 (2) 0.28663 (15) −0.00562 (17) 0.1223 (5)
O1 0.85574 (3) 0.18095 (14) 0.0915 (2) 0.0407 (4)
O2 0.77454 (3) 0.07687 (14) 0.0967 (2) 0.0425 (4)
O3 0.62394 (4) 0.0180 (2) 0.2485 (3) 0.0729 (6)
N1 0.86735 (5) −0.00435 (19) −0.0435 (3) 0.0519 (5)
N2 0.83462 (4) −0.00355 (19) −0.0042 (3) 0.0487 (5)
N3 0.65271 (4) 0.19545 (18) 0.3324 (3) 0.0446 (4)
H3 0.651157 0.270429 0.383345 0.053*
C1 0.91898 (6) 0.2770 (3) 0.0713 (4) 0.0552 (6)
H1 0.903405 0.332106 0.114707 0.066*
C2 0.95026 (7) 0.3187 (3) 0.0652 (4) 0.0723 (8)
H2 0.955862 0.401652 0.105345 0.087*
C3 0.97283 (6) 0.2357 (4) −0.0008 (4) 0.0742 (9)
C4 0.96543 (6) 0.1127 (4) −0.0627 (4) 0.0737 (8)
H4 0.981049 0.058641 −0.108061 0.088*
C5 0.93441 (6) 0.0710 (3) −0.0564 (4) 0.0623 (7)
H5 0.929027 −0.011804 −0.097927 0.075*
C6 0.91116 (5) 0.1521 (2) 0.0118 (3) 0.0462 (5)
C7 0.87852 (5) 0.1050 (2) 0.0164 (3) 0.0417 (5)
C8 0.82940 (5) 0.1064 (2) 0.0735 (3) 0.0392 (5)
C9 0.79968 (5) 0.1607 (2) 0.1473 (3) 0.0395 (5)
H9A 0.801380 0.166062 0.276309 0.047*
H9B 0.795908 0.247872 0.100672 0.047*
C10 0.74482 (5) 0.11247 (18) 0.1555 (3) 0.0345 (4)
C11 0.72024 (5) 0.02966 (19) 0.1083 (3) 0.0376 (4)
H11 0.724354 −0.043669 0.039235 0.045*
C12 0.68942 (5) 0.05388 (19) 0.1623 (3) 0.0393 (5)
H12 0.673114 −0.002716 0.129254 0.047*
C13 0.68317 (5) 0.16400 (19) 0.2665 (3) 0.0356 (4)
C14 0.70774 (5) 0.24918 (19) 0.3082 (3) 0.0377 (4)
H14 0.703636 0.324139 0.374048 0.045*
C15 0.73839 (5) 0.22421 (19) 0.2532 (3) 0.0376 (4)
H15 0.754604 0.282438 0.281810 0.045*
C16 0.62573 (5) 0.1230 (2) 0.3258 (3) 0.0481 (5)
C17 0.59772 (6) 0.1809 (3) 0.4218 (4) 0.0633 (7)
H17A 0.579119 0.174637 0.346840 0.095*
H17B 0.601896 0.271026 0.448890 0.095*
H17C 0.594398 0.133676 0.530577 0.095*

N-(4-{[5-(4-Chlorophenyl)-1,3,4-oxadiazol-2-yl]methoxy}phenyl)acetamide (II) . Atomic displacement parameters (Å2)

U11 U22 U33 U12 U13 U23
Cl1 0.0409 (4) 0.1918 (13) 0.1346 (10) −0.0285 (6) 0.0098 (5) −0.0347 (9)
O1 0.0337 (7) 0.0388 (7) 0.0495 (9) 0.0005 (6) 0.0009 (6) 0.0002 (6)
O2 0.0347 (7) 0.0388 (7) 0.0541 (9) −0.0004 (6) 0.0022 (6) −0.0049 (6)
O3 0.0530 (10) 0.0679 (12) 0.0983 (15) −0.0194 (10) 0.0142 (10) −0.0212 (11)
N1 0.0459 (10) 0.0484 (11) 0.0618 (12) 0.0004 (9) 0.0093 (9) −0.0053 (9)
N2 0.0445 (10) 0.0434 (10) 0.0583 (12) −0.0042 (8) 0.0070 (8) −0.0058 (8)
N3 0.0391 (9) 0.0393 (9) 0.0554 (11) 0.0024 (8) 0.0032 (8) −0.0038 (8)
C1 0.0397 (12) 0.0612 (15) 0.0648 (15) −0.0029 (11) 0.0036 (11) −0.0073 (12)
C2 0.0495 (15) 0.085 (2) 0.082 (2) −0.0147 (14) −0.0027 (14) −0.0151 (17)
C3 0.0378 (13) 0.112 (3) 0.0733 (19) −0.0085 (15) 0.0046 (12) −0.0051 (18)
C4 0.0419 (13) 0.097 (2) 0.083 (2) 0.0130 (15) 0.0095 (13) −0.0038 (17)
C5 0.0491 (13) 0.0675 (16) 0.0708 (17) 0.0051 (12) 0.0107 (12) −0.0023 (13)
C6 0.0377 (11) 0.0514 (12) 0.0495 (12) 0.0033 (10) 0.0006 (9) 0.0048 (10)
C7 0.0389 (11) 0.0408 (11) 0.0453 (11) 0.0062 (9) 0.0024 (8) 0.0030 (9)
C8 0.0394 (10) 0.0375 (10) 0.0407 (10) −0.0029 (8) −0.0008 (8) 0.0062 (8)
C9 0.0372 (10) 0.0380 (10) 0.0433 (11) −0.0016 (8) 0.0000 (8) 0.0017 (8)
C10 0.0357 (10) 0.0328 (9) 0.0349 (9) 0.0008 (8) −0.0011 (7) 0.0032 (7)
C11 0.0414 (10) 0.0306 (9) 0.0407 (10) 0.0013 (8) −0.0034 (8) −0.0029 (8)
C12 0.0356 (10) 0.0363 (10) 0.0458 (11) −0.0044 (8) −0.0033 (8) −0.0015 (8)
C13 0.0344 (10) 0.0338 (9) 0.0385 (10) 0.0017 (8) −0.0009 (8) 0.0034 (8)
C14 0.0430 (11) 0.0306 (9) 0.0393 (10) 0.0014 (8) −0.0002 (8) −0.0023 (8)
C15 0.0376 (10) 0.0329 (9) 0.0423 (11) −0.0061 (8) −0.0027 (8) −0.0011 (8)
C16 0.0398 (11) 0.0518 (13) 0.0529 (13) −0.0011 (10) 0.0007 (9) 0.0055 (10)
C17 0.0422 (13) 0.0750 (18) 0.0729 (17) 0.0050 (12) 0.0125 (12) 0.0086 (14)

N-(4-{[5-(4-Chlorophenyl)-1,3,4-oxadiazol-2-yl]methoxy}phenyl)acetamide (II) . Geometric parameters (Å, º)

Cl1—C3 1.746 (3) C5—C6 1.390 (3)
O1—C8 1.354 (2) C5—H5 0.9300
O1—C7 1.366 (2) C6—C7 1.461 (3)
O2—C10 1.386 (2) C8—C9 1.488 (3)
O2—C9 1.412 (2) C9—H9A 0.9700
O3—C16 1.222 (3) C9—H9B 0.9700
N1—C7 1.292 (3) C10—C11 1.381 (3)
N1—N2 1.419 (3) C10—C15 1.387 (3)
N2—C8 1.288 (3) C11—C12 1.392 (3)
N3—C16 1.359 (3) C11—H11 0.9300
N3—C13 1.423 (3) C12—C13 1.399 (3)
N3—H3 0.8600 C12—H12 0.9300
C1—C2 1.390 (4) C13—C14 1.387 (3)
C1—C6 1.391 (4) C14—C15 1.390 (3)
C1—H1 0.9300 C14—H14 0.9300
C2—C3 1.376 (4) C15—H15 0.9300
C2—H2 0.9300 C16—C17 1.516 (3)
C3—C4 1.375 (5) C17—H17A 0.9600
C4—C5 1.380 (4) C17—H17B 0.9600
C4—H4 0.9300 C17—H17C 0.9600
C8—O1—C7 102.84 (16) O2—C9—H9A 110.1
C10—O2—C9 115.84 (15) C8—C9—H9A 110.1
C7—N1—N2 105.90 (18) O2—C9—H9B 110.1
C8—N2—N1 105.93 (18) C8—C9—H9B 110.1
C16—N3—C13 128.78 (19) H9A—C9—H9B 108.4
C16—N3—H3 115.6 C11—C10—O2 115.99 (17)
C13—N3—H3 115.6 C11—C10—C15 119.16 (19)
C2—C1—C6 119.5 (2) O2—C10—C15 124.84 (18)
C2—C1—H1 120.3 C10—C11—C12 121.27 (18)
C6—C1—H1 120.3 C10—C11—H11 119.4
C3—C2—C1 119.2 (3) C12—C11—H11 119.4
C3—C2—H2 120.4 C11—C12—C13 119.49 (18)
C1—C2—H2 120.4 C11—C12—H12 120.3
C4—C3—C2 122.1 (3) C13—C12—H12 120.3
C4—C3—Cl1 118.5 (3) C14—C13—C12 118.97 (19)
C2—C3—Cl1 119.4 (3) C14—C13—N3 117.19 (18)
C3—C4—C5 118.8 (3) C12—C13—N3 123.84 (18)
C3—C4—H4 120.6 C13—C14—C15 120.99 (18)
C5—C4—H4 120.6 C13—C14—H14 119.5
C4—C5—C6 120.4 (3) C15—C14—H14 119.5
C4—C5—H5 119.8 C10—C15—C14 120.03 (18)
C6—C5—H5 119.8 C10—C15—H15 120.0
C5—C6—C1 120.0 (2) C14—C15—H15 120.0
C5—C6—C7 119.0 (2) O3—C16—N3 122.8 (2)
C1—C6—C7 120.9 (2) O3—C16—C17 121.7 (2)
N1—C7—O1 112.35 (19) N3—C16—C17 115.5 (2)
N1—C7—C6 128.0 (2) C16—C17—H17A 109.5
O1—C7—C6 119.63 (19) C16—C17—H17B 109.5
N2—C8—O1 112.97 (18) H17A—C17—H17B 109.5
N2—C8—C9 130.30 (19) C16—C17—H17C 109.5
O1—C8—C9 116.72 (17) H17A—C17—H17C 109.5
O2—C9—C8 107.97 (17) H17B—C17—H17C 109.5
C7—N1—N2—C8 0.6 (3) C7—O1—C8—N2 −0.2 (2)
C6—C1—C2—C3 0.5 (5) C7—O1—C8—C9 178.65 (17)
C1—C2—C3—C4 0.6 (5) C10—O2—C9—C8 179.63 (16)
C1—C2—C3—Cl1 −179.1 (2) N2—C8—C9—O2 −8.3 (3)
C2—C3—C4—C5 −0.7 (5) O1—C8—C9—O2 173.06 (16)
Cl1—C3—C4—C5 178.9 (2) C9—O2—C10—C11 −179.13 (17)
C3—C4—C5—C6 −0.1 (5) C9—O2—C10—C15 2.1 (3)
C4—C5—C6—C1 1.1 (4) O2—C10—C11—C12 178.85 (18)
C4—C5—C6—C7 179.9 (2) C15—C10—C11—C12 −2.3 (3)
C2—C1—C6—C5 −1.3 (4) C10—C11—C12—C13 −0.1 (3)
C2—C1—C6—C7 179.9 (2) C11—C12—C13—C14 2.3 (3)
N2—N1—C7—O1 −0.8 (3) C11—C12—C13—N3 −178.20 (19)
N2—N1—C7—C6 179.2 (2) C16—N3—C13—C14 −172.9 (2)
C8—O1—C7—N1 0.6 (2) C16—N3—C13—C12 7.6 (4)
C8—O1—C7—C6 −179.32 (18) C12—C13—C14—C15 −2.1 (3)
C5—C6—C7—N1 −3.4 (4) N3—C13—C14—C15 178.33 (19)
C1—C6—C7—N1 175.5 (2) C11—C10—C15—C14 2.5 (3)
C5—C6—C7—O1 176.6 (2) O2—C10—C15—C14 −178.79 (18)
C1—C6—C7—O1 −4.6 (3) C13—C14—C15—C10 −0.2 (3)
N1—N2—C8—O1 −0.3 (2) C13—N3—C16—O3 −4.4 (4)
N1—N2—C8—C9 −178.9 (2) C13—N3—C16—C17 175.4 (2)

N-(4-{[5-(4-Chlorophenyl)-1,3,4-oxadiazol-2-yl]methoxy}phenyl)acetamide (II) . Hydrogen-bond geometry (Å, º)

D—H···A D—H H···A D···A D—H···A
C1—H1···O1 0.93 2.54 2.853 (3) 100
N3—H3···N2i 0.86 2.55 3.377 (3) 161
C1—H1···O3i 0.93 2.46 3.359 (3) 163
C14—H14···N2i 0.93 2.59 3.443 (3) 152
C17—H17C···O3ii 0.96 2.56 3.357 (4) 140

Symmetry codes: (i) −x+3/2, y+1/2, −z+1/2; (ii) x, −y, z+1/2.

Funding Statement

This work was funded by Department of Biotechnology , Ministry of Science and Technology grant BT/PR16268/NER/95/183/2015.

References

  1. Bruker (2002). SMART, and SAINT. Bruker AXS Inc., Madison, Wisconsin, U. S. A.
  2. Farrugia, L. J. (2012). J. Appl. Cryst. 45, 849–854.
  3. Gans, J. D. & Shalloway, D. (2001). J. Mol. Graph. Model. 19, 557–559. [DOI] [PubMed]
  4. Guimarães, C. R. W., Boger, D. L. & Jorgensen, W. L. (2005). J. Am. Chem. Soc. 127, 17377–17384. [DOI] [PubMed]
  5. Pace, A. & Pierro, P. (2009). Org. Biomol. Chem. 7, 4337–4348. [DOI] [PubMed]
  6. Rigo, B. & Couturier, D. J. (1985). Heterocycl. Chem. 22, 287–288.
  7. Sheldrick, G. M. (2008). Acta Cryst. A64, 112–122. [DOI] [PubMed]
  8. Sheldrick, G. M. (2015). Acta Cryst. C71, 3–8.
  9. Spek, A. L. (2009). Acta Cryst. D65, 148–155. [DOI] [PMC free article] [PubMed]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Crystal structure: contains datablock(s) I, II, global. DOI: 10.1107/S2056989018016754/zq2243sup1.cif

e-74-01919-sup1.cif (1.1MB, cif)

Structure factors: contains datablock(s) I. DOI: 10.1107/S2056989018016754/zq2243Isup2.hkl

e-74-01919-Isup2.hkl (286.6KB, hkl)

Structure factors: contains datablock(s) II. DOI: 10.1107/S2056989018016754/zq2243IIsup4.hkl

e-74-01919-IIsup4.hkl (291.6KB, hkl)

Supporting information file. DOI: 10.1107/S2056989018016754/zq2243Isup4.cml

Supporting information file. DOI: 10.1107/S2056989018016754/zq2243IIsup5.cml

CCDC references: 1881075, 1881074

Additional supporting information: crystallographic information; 3D view; checkCIF report


Articles from Acta Crystallographica Section E: Crystallographic Communications are provided here courtesy of International Union of Crystallography

RESOURCES